At a glance
- Originator Pharmacia Corporation
- Class Antiglaucomas; Prostaglandins; Small molecules; Synthetic prostaglandins
- Mechanism of Action Prostaglandin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Glaucoma
Most Recent Events
- 16 Apr 2003 Pharmacia has been acquired by Pfizer
- 06 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 18 Jun 1998 Phase-II clinical trials for Glaucoma in Sweden (Ophthalmic)